Influenza vaccination coverage among an urban pediatric asthma population : Implications for population health

INTRODUCTION: Asthma is the most common chronic disease in children. Children with asthma are at high risk for complications from influenza; however annual influenza vaccination rates for this population are suboptimal. The overall aim of this study was to describe the characteristics of a high-risk population of children with asthma presenting to an urban pediatric emergency department according to influenza vaccination status.

METHODS: The study was a retrospective chart review of 4355 patients aged 2 to 18 years evaluated in a Michigan pediatric emergency department (PED) between November 1, 2017 and April 30, 2018 with an ICD-10-CM code for asthma (J45.x). Eligible patient PED records were matched with influenza vaccination records for the 2017-2018 influenza season from the Michigan Care Improvement Registry. Geospatial analysis was employed to examine the distribution of influenza vaccination status.

RESULTS: 1049 patients (30.9%) with asthma seen in the PED had received an influenza vaccine. Influenza vaccination coverage varied by Census Tract, ranging from 10% to >99%. Most vaccines were administered in a primary care setting (84.3%) and were covered by public insurance (76.8%). The influenza vaccination rate was lowest for children aged 5-11 years (30.0%) and vaccination status was associated with race (p<0.001) and insurance type (p<0.001).

CONCLUSIONS: Identification of neighborhood Census Tract and demographic groups with suboptimal influenza vaccination could guide development of targeted public health interventions to improve vaccination rates in high-risk patients. Given the morbidity and mortality associated with pediatric asthma, a data-driven approach may improve outcomes and reduce healthcare-associated costs for this pediatric population.

Medienart:

E-Artikel

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

Zur Gesamtaufnahme - volume:17

Enthalten in:

PloS one - 17(2022), 10 vom: 15., Seite e0269415

Sprache:

Englisch

Beteiligte Personen:

Parker, Sarah J [VerfasserIn]
DeLaroche, Amy M [VerfasserIn]
Hill, Alex B [VerfasserIn]
Arora, Rajan [VerfasserIn]
Gleason-Comstock, Julie [VerfasserIn]

Links:

Volltext

Themen:

Influenza Vaccines
Journal Article

Anmerkungen:

Date Completed 25.10.2022

Date Revised 25.10.2022

published: Electronic-eCollection

Citation Status MEDLINE

doi:

10.1371/journal.pone.0269415

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM347843360